Superoxide Anion Generation in Human Milk Macrophages: Opsonin-Dependent Versus Opsonin-Independent Stimulation Compared with Blood Monocytes

Total Page:16

File Type:pdf, Size:1020Kb

Superoxide Anion Generation in Human Milk Macrophages: Opsonin-Dependent Versus Opsonin-Independent Stimulation Compared with Blood Monocytes 0031-3998/01/4903-0435 PEDIATRIC RESEARCH Vol. 49, No. 3, 2001 Copyright © 2001 International Pediatric Research Foundation, Inc. Printed in U.S.A. Superoxide Anion Generation in Human Milk Macrophages: Opsonin-Dependent Versus Opsonin-Independent Stimulation Compared with Blood Monocytes RÜDIGER ADAM, FRANK KUCZERA, HENRIK KÖHLER, AND HORST SCHROTEN Zentrum für Kinderheilkunde, Heinrich-Heine-Universität, 40225 Düsseldorf, Germany ABSTRACT Macrophages are believed to play an important role within the found when unopsonized zymosan was used. After addition of - immunoprotective effects of human breast milk. It was the cytochalasin B, equal inhibition of O2 generation was observed purpose of this study to evaluate the capability of human milk regardless of the cell type or stimulus used. Thus, MM⌽ are ⌽ - macrophages (MM ) to generate superoxide anions (O2 )in stimulated to a greater extent by serum-independent mechanisms comparison with peripheral blood monocytes (BMo) after stim- than BMo. As opsonins like complement or IgG are rare in the ulation with opsonized and unopsonized zymosan. Potential in- colostrum and the neonatal intestinal environment, such a differ- hibitors of attachment and phagocytosis such as mannose and entiation toward serum-independent phagocytic abilities could cytochalasin B were used. Expression of the mannose receptor on play an important role for protective functions of human MM⌽. MM⌽ was demonstrated by staining with MAb. BMo generated Possible involvement of the mannose receptor and the ␤-glucan - ⌽ Ϯ Ϯ - more O2 than MM (417 79 versus 216 15 nmol O2 /mg receptor in this specialization are discussed. (Pediatr Res 49: protein, p Ͻ 0.05) after stimulation with opsonized zymosan. 435–439, 2001) When unopsonized zymosan was used as a serum-independent - stimulus, BMo generated slightly less O2 in comparison with ⌽ Ϯ Ϯ - Ͻ MM (150 34 versus 176 18 nmol O2 /mg protein, p Abbreviations 0.05). These findings imply a higher proportion of opsonin- MM⌽, milk macrophages independent phagocytosis in MM⌽ than in BMo (82 versus BMo, blood monocytes - -1 -1 - -1 -1 36%). Preincubation with mannose resulted in a significantly nmol O2 ·mg p ·30' , nmol O2 ·mg protein ·30 min - ⌽ higher reduction of O2 generation in MM compared with BMo MR, mannose receptor stimulated with opsonized zymosan, whereas no difference was CR3, complement receptor type 3 Besides well-known nutritional benefits, transfer of antimi- different subclasses of IgG, IgA, and C3b receptors and syn- crobial activity is of great importance in infant breast-feeding. thesize various humoral defensive factors such as complement A great variety of humoral defense factors (e.g. secretory Ig, factors, lactoferrin, and lysozyme (1–5). especially sIgA, lactoferrin, lysozyme, oligosaccharides, mu- Because human MM⌽ remain viable in conditions similar to cins, and others) contribute to the beneficial effects. In addition, those in the small intestine (6), show relative resistance to an large numbers of viable cells are present in human colostrum environment with a pH Ͻ3, and resist trypsinization (7), it seems and breast milk with a high proportion of macrophages likely very likely that MM⌽ can develop their immunoprotective func- being responsible for antiinfectious properties. tions within the gastrointestinal tract of the breast-fed baby. These human MM⌽ with a diameter of 18 to 40 ␮m contain Interaction of macrophage membrane receptors with com- a high amount of phagocytosed lipids, “foamy cells.” Their plementary coating substances on a pathogen’s surface is well morphologic and cytochemical properties are similar to differ- described as opsonophagocytosis. These coatings (opsonins), entiated macrophages. For example, they bear Fc receptors for derived from various sites of the hosts immune system, consist of bridging serum factors such as Ig, the iC3b fragment of C3 complement factor, C-reactive protein, surfactant proteins A Received February 29, 2000; accepted September 22, 2000. Correspondence: Horst Schroten, M.D., Zentrum für Kinderheilkunde, Heinrich-Heine- and D, and the mannose-binding protein (8). Universität, Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany. Interaction of carbohydrate-binding proteins termed lectins Presented in part at the 17th Scientific Congress of the European Society for Pediatric Hematology and Immunology, Washington, D.C., U.S.A., May 11–15, 1999. with complementary carbohydrate chains is another primary Published in abstract form in Pediatric Research 45:744, 1999. mechanism of mediating attachment of pathogens. This phago- 435 436 ADAM ET AL. cytic process, known as serum independent or lectinophago- ethylmaleimide stopped the induced oxidative metabolism af- cytosis, is promoted, for example, through the MR or a lectin ter treatment with the stimulants for 30 min. Reduction of site on the CD11b/CD18 (MAC-1) integrin, the ␤-glucan cytochrome c was quantified spectrophotometrically (550 nm). receptor (8). The assay was repeated with superoxide dismutase to correct After recognition and attachment of pathogenetic particles, for oxygen-independent reduction of cytochrome c. Results - the process of phagocytosis progresses with different patterns were expressed in nmol O2 /mg protein. of internalization and mostly culminates in the triggering of the respiratory burst with the release of microbicidal oxygen me- Stimulating Agents tabolites. It is hypothesized that due to a lower availability of opsonizing factors in the milk (9) and the gastrointestinal tract Opsonized and unopsonized zymosan (Sigma Chemical Co., of the infant, human MM⌽ are activated by other mechanisms St. Louis, MO, U.S.A.) was used as a stimulus. Serum from than BMo. healthy donors was taken for opsonization. The zymosan par- Therefore, this study was undertaken to investigate opsono- ticles were autoclaved for 30 min, washed twice with PBS, and ϫ 5 and lectinophagocytic properties of human MM⌽ by measur- resuspended in PBS. The samples were adjusted to 2 10 - particles/␮L and stored at Ϫ70°C until further use. ing the superoxide anion (O2 ) production in comparison with human BMo after stimulation with opsonized and unopsonized zymosan particles. D-Mannose and cytochalasin B as potential Inhibitors inhibitors were used to evaluate attachment and engulfment Mannose and cytochalasin B (Sigma Chemical Co., St. mechanisms. Louis, U.S.A.) were used as potential inhibitors. Two millili- ters of each substance was incubated with the isolated cells for METHODS 15 min at 37°C before the stimulation assay. Mannose was Collection, Preparation, and Culture of Cells prepared in 0.1, 0.25, and 0.5-M solutions, and cytochalasin B was used at a concentration of 1 ␮g/mL. All assays were Human milk was collected from 38 healthy lactating women performed in duplicate. 1–6 d postpartum by hand expression with informed consent at the Department of Gynecology and Obstetrics, Heinrich- Expression of MR Heine-Universität Düsseldorf, Germany, after having obtained approval of the Clinic’s Review Board. The samples were Phagocytes were stained with a monoclonal murine antibody generally obtained before the infants were fed and stored at generated against the human MR (Pharmingen, San Diego, room temperature for up to4hinsterile containers. CA, U.S.A.). BMo and MM⌽ were prepared as described The milk was skimmed by 1:1 dilution with PBS and above and subsequently incubated with the anti-MR antibodies centrifuged at 4°C and 600 ϫ g for 10 min. The pellet was (20 ␮L per pellet) for 10 min, washed with PBS, and centri- resuspended in 25 mL PBS, layered on 25 mL Ficoll-Hypaque fuged at 300 ϫ g for 10 min at 20°C. Staining was evaluated (Pharmacia, Uppsala, Sweden), and centrifuged at 20°C and using a fluorescence microscope (Zeiss Optics, Göttingen, 1000 ϫ g for 20 min. The mononuclear interface cell layer was Germany). washed in PBS and RPMI (GIBCO, NY, U.S.A.) (supplement- ed with penicillin, gentamicin, HEPES, FCS, and glutamine) Statistical Analysis and resuspended in RPMI (with supplements). Purity (Ͼ90%) Statistical analysis was performed by using the paired t test. of the cell preparation was assessed by naphthyl acetate ester- An ␣ error of p Ͻ 0.05 was regarded as significant. ase staining. Cells were enumerated by cell counter (Coulter, Krefeld, Germany) and adjusted at a concentration of 2.5 ϫ RESULTS 105 cells/mL. Monocytic viability of Ն95% was assured by trypan blue exclusion. Two milliliters of the cell suspension Stimulation without Inhibitors were prepared in plastic culture dishes, and cells were allowed - Ϯ to adhere for2hat37°C and 5% CO , then washed vigorously Without any additional stimuli, a O2 production of 40 3 2 - -1 -1 ⌽ Ϯ - with PBS to remove nonadherent cells. nmol O2 ·mg p ·30' in MM and 47 4.7 nmol O2 ·mg -1 -1 Monocytes were isolated from heparinized human blood p ·30' in BMo was measured. After stimulation with opso- Ϯ - from 64 healthy volunteers as described above by Ficoll- nized zymosan, BMo generated 417 79 nmol O2 ·mg -1 -1 ⌽ Ϯ - -1 -1 Hypaque gradient and then treated like the MM⌽. p ·30' , and MM generated 216 15 nmol O2 ·mg p ·30' . Ϯ The protein content in the samples was determined accord- When unopsonized zymosan was used, BMo produced 150 - -1 -1 ⌽ Ϯ ing to the method of Lowry et al. (10). Only samples with a 35 nmol O2 ·mg p ·30' , and MM generated 176 18 nmol - -1 -1 protein content between 40 and 100 ␮g were used (11). The O2 ·mg p ·30' . Thus, peripheral BMo released a higher ab- - ⌽ cells were stored in PBS on ice (maximum, 15 min) until use. solute amount of O2 than human MM when stimulated with - opsonized zymosan, whereas O2 production after activation with unopsonized zymosan demonstrated approximately equal O - Production 2 release of the measured oxygen metabolites. Notably, MM⌽ - - O2 production was measured by reduction of superoxide showed a significantly higher proportion of O2 generation dismutase-sensitive cytochrome c. Addition of 2 mL N- under opsonin-independent stimulation (100 to 82%) than - O2 PRODUCTION IN MILK MACROPHAGES 437 BMo (100 to 36%) in relation to opsonin-dependent stimula- tion (Fig.
Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Macrophage Activation Markers, CD163 and CD206, in Acute-On-Chronic Liver Failure
    cells Review Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure Marlene Christina Nielsen 1 , Rasmus Hvidbjerg Gantzel 2 , Joan Clària 3,4 , Jonel Trebicka 3,5 , Holger Jon Møller 1 and Henning Grønbæk 2,* 1 Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus N, Denmark; [email protected] (M.C.N.); [email protected] (H.J.M.) 2 Department of Hepatology & Gastroenterology, Aarhus University Hospital, 8200 Aarhus N, Denmark; [email protected] 3 European Foundation for the Study of Chronic Liver Failure (EF-CLIF), 08021 Barcelona, Spain; [email protected] (J.C.); [email protected] (J.T.) 4 Department of Biochemistry and Molecular Genetics, Hospital Clínic-IDIBAPS, 08036 Barcelona, Spain 5 Translational Hepatology, Department of Internal Medicine I, Goethe University Frankfurt, 60323 Frankfurt, Germany * Correspondence: [email protected]; Tel.: +45-21-67-92-81 Received: 1 April 2020; Accepted: 4 May 2020; Published: 9 May 2020 Abstract: Macrophages facilitate essential homeostatic functions e.g., endocytosis, phagocytosis, and signaling during inflammation, and express a variety of scavenger receptors including CD163 and CD206, which are upregulated in response to inflammation. In healthy individuals, soluble forms of CD163 and CD206 are constitutively shed from macrophages, however, during inflammation pathogen- and damage-associated stimuli induce this shedding. Activation of resident liver macrophages viz. Kupffer cells is part of the inflammatory cascade occurring in acute and chronic liver diseases. We here review the existing literature on sCD163 and sCD206 function and shedding, and potential as biomarkers in acute and chronic liver diseases with a particular focus on Acute-on-Chronic Liver Failure (ACLF).
    [Show full text]
  • In Sickness and in Health: the Immunological Roles of the Lymphatic System
    International Journal of Molecular Sciences Review In Sickness and in Health: The Immunological Roles of the Lymphatic System Louise A. Johnson MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK; [email protected] Abstract: The lymphatic system plays crucial roles in immunity far beyond those of simply providing conduits for leukocytes and antigens in lymph fluid. Endothelial cells within this vasculature are dis- tinct and highly specialized to perform roles based upon their location. Afferent lymphatic capillaries have unique intercellular junctions for efficient uptake of fluid and macromolecules, while expressing chemotactic and adhesion molecules that permit selective trafficking of specific immune cell subsets. Moreover, in response to events within peripheral tissue such as inflammation or infection, soluble factors from lymphatic endothelial cells exert “remote control” to modulate leukocyte migration across high endothelial venules from the blood to lymph nodes draining the tissue. These immune hubs are highly organized and perfectly arrayed to survey antigens from peripheral tissue while optimizing encounters between antigen-presenting cells and cognate lymphocytes. Furthermore, subsets of lymphatic endothelial cells exhibit differences in gene expression relating to specific func- tions and locality within the lymph node, facilitating both innate and acquired immune responses through antigen presentation, lymph node remodeling and regulation of leukocyte entry and exit. This review details the immune cell subsets in afferent and efferent lymph, and explores the mech- anisms by which endothelial cells of the lymphatic system regulate such trafficking, for immune surveillance and tolerance during steady-state conditions, and in response to infection, acute and Citation: Johnson, L.A.
    [Show full text]
  • The Case for Lupus Nephritis
    Journal of Clinical Medicine Review Expanding the Role of Complement Therapies: The Case for Lupus Nephritis Nicholas L. Li * , Daniel J. Birmingham and Brad H. Rovin Department of Internal Medicine, Division of Nephrology, The Ohio State University, Columbus, OH 43210, USA; [email protected] (D.J.B.); [email protected] (B.H.R.) * Correspondence: [email protected]; Tel.: +1-614-293-4997; Fax: +1-614-293-3073 Abstract: The complement system is an innate immune surveillance network that provides defense against microorganisms and clearance of immune complexes and cellular debris and bridges innate and adaptive immunity. In the context of autoimmune disease, activation and dysregulation of complement can lead to uncontrolled inflammation and organ damage, especially to the kidney. Systemic lupus erythematosus (SLE) is characterized by loss of tolerance, autoantibody production, and immune complex deposition in tissues including the kidney, with inflammatory consequences. Effective clearance of immune complexes and cellular waste by early complement components protects against the development of lupus nephritis, while uncontrolled activation of complement, especially the alternative pathway, promotes kidney damage in SLE. Therefore, complement plays a dual role in the pathogenesis of lupus nephritis. Improved understanding of the contribution of the various complement pathways to the development of kidney disease in SLE has created an opportunity to target the complement system with novel therapies to improve outcomes in lupus nephritis. In this review, we explore the interactions between complement and the kidney in SLE and their implications for the treatment of lupus nephritis. Keywords: lupus nephritis; complement; systemic lupus erythematosus; glomerulonephritis Citation: Li, N.L.; Birmingham, D.J.; Rovin, B.H.
    [Show full text]
  • Opsonin-Dependent Stimulation of Bovine Neutrophil Oxidative Metabolism by Brucella Abortus Peter C
    Veterinary Microbiology and Preventive Medicine Veterinary Microbiology and Preventive Medicine Publications 2-1988 Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Peter C. Canning U.S. Department of Agriculture Billy L. Deyoe U.S. Department of Agriculture James A. Roth Iowa State University, [email protected] Follow this and additional works at: https://lib.dr.iastate.edu/vmpm_pubs Part of the Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Veterinary Toxicology and Pharmacology Commons The ompc lete bibliographic information for this item can be found at https://lib.dr.iastate.edu/ vmpm_pubs/190. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Veterinary Microbiology and Preventive Medicine at Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Microbiology and Preventive Medicine Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Abstract Nonopsonized Brucella abortus and bacteria treated with fresh antiserum, heat-inactivated antiserum, or normal bovine serum were evaluated for their ability to stimulate production of superoxide anion and myeloperoxidasemediated iodination by neutrophils from cattle. Brucella abortus opsonized with fresh antiserum or beat-inactivated antiserum stimulated production of approximately 3 nmol of 0 2 -/106 neutrophils/30 min. Similarly treated bacteria also stimulated the binding of approximately 4.3 nmol of Nal/ 107 neutrophils/h to protein.
    [Show full text]
  • Instant Notes: Immunology, Second Edition
    Immunology Second Edition The INSTANT NOTES series Series Editor: B.D. Hames School of Biochemistry and Molecular Biology, University of Leeds, Leeds, UK Animal Biology 2nd edition Biochemistry 2nd edition Bioinformatics Chemistry for Biologists 2nd edition Developmental Biology Ecology 2nd edition Immunology 2nd edition Genetics 2nd edition Microbiology 2nd edition Molecular Biology 2nd edition Neuroscience Plant Biology Chemistry series Consulting Editor: Howard Stanbury Analytical Chemistry Inorganic Chemistry 2nd edition Medicinal Chemistry Organic Chemistry 2nd edition Physical Chemistry Psychology series Sub-series Editor: Hugh Wagner Dept of Psychology, University of Central Lancashire, Preston, UK Psychology Cognitive Psychology Forthcoming title Physiological Psychology Immunology Second Edition P.M. Lydyard Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, University College London, London, UK A. Whelan Department of Immunology, Trinity College and St James’ Hospital, Dublin, Ireland and M.W. Fanger Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire, USA © Garland Science/BIOS Scientific Publishers Limited, 2004 First published 2000 This edition published in the Taylor & Francis e-Library, 2005. “To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.” Second edition published 2004 All rights reserved. No part of this book may be reproduced or
    [Show full text]
  • Insights Into Interactions of Mycobacteria with the Host Innate
    This is an open access article published under a Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. Articles pubs.acs.org/acschemicalbiology Insights into Interactions of Mycobacteria with the Host Innate Immune System from a Novel Array of Synthetic Mycobacterial Glycans † ‡ † † † † Ruixiang Blake Zheng, Sabine A. F. Jegouzo,́ Maju Joe, Yu Bai, Huu-Anh Tran, Ke Shen, † † † † § § Jörn Saupe, Li Xia, Md. Faiaz Ahmed, Yu-Hsuan Liu, Pratap Subhashrao Patil, Ashish Tripathi, § ‡ † ‡ Shang-Cheng Hung, Maureen E. Taylor,*, Todd L. Lowary,*, and Kurt Drickamer*, † Department of Chemistry and Alberta Glycomics Centre, University of Alberta, Edmonton, AB T6G 2G2, Canada ‡ Department of Life Sciences, Imperial College, London SW7 2AZ, United Kingdom § Genomics Research Centre, Academia Sinica, Nangang, Taipei 11529, Taiwan *S Supporting Information ABSTRACT: An array of homogeneous glycans representing all the major carbohydrate structures present in the cell wall of the human pathogen Mycobacterium tuberculosis and other mycobacteria has been probed with a panel of glycan-binding receptors expressed on cells of the mammalian innate immune system. The results provide an overview of interactions between mycobacterial glycans and receptors that mediate uptake and survival in macrophages, dendritic cells, and sinusoidal endothelial cells. A subset of the wide variety of glycan structures present on mycobacterial surfaces interact with cells of the innate immune system through the receptors tested. Endocytic receptors, including the mannose receptor, DC-SIGN, langerin, and DC-SIGNR (L-SIGN), interact predominantly with mannose-containing caps found on the mycobacterial polysaccharide lipoarabinomannan. Some of these receptors also interact with phosphatidyl-myo-inositol mannosides and mannose-containing phenolic glycolipids.
    [Show full text]
  • Complement Herbert L
    Host Defense 2011 Complement Herbert L. Mathews, Ph.D. COMPLEMENT Date: 4/11/11 Reading Assignment: Janeway’s Immunobiology, 7th Edition, pp. 54-55, 61-82, 406- 409, 514-515. Figures: (Unless otherwise noted) Janeway’s Immunobiology, 7th Edition, Murphy et al., Garland Publishing. KEY CONCEPTS AND LEARNING OBJECTIVES You will be able to describe the mechanism and consequences of the activation of the complement system. To attain the goals for these lectures you will be able to: a. List the components of the complement system. b. Describe the three activation pathways for complement. c. Explain the consequences of complement activation. d. Describe the consequence of complement deficiency. Page 1 Host Defense 2011 Complement Herbert L. Mathews, Ph.D. CONTENT SUMMARY Introduction Nomenclature Activation of Complement The classical pathway The mannan-binding lectin pathway The alternative pathway Biological Consequence of Complement Activation Cell lysis and viral neutralization Opsonization Clearance of Immune Complexes Inflammation Regulation of Complement Activation Human Complement Component Deficiencies Page 2 Host Defense 2011 Complement Herbert L. Mathews, Ph.D. Introduction The complement system is a group of more than 30 plasma and membrane proteins that play a critical role in host defense. When activated, complement components interact in a highly regulated fashion to generate products that: Recruit inflammatory cells (promoting inflammation). Opsonize microbial pathogens and immune complexes (facilitating antigen clearance). Kill microbial pathogens (via a lytic mechanism known as the membrane attack complex). Generate an inflammatory response. Complement activation takes place on antigenic surfaces. However, the activation of complement generates several soluble fragments that have important biologic activity.
    [Show full text]
  • The Role of Langerin Transfer From
    Inhibition of Two Temporal Phases of HIV-1 Transfer from Primary Langerhans Cells to T Cells: The Role of Langerin This information is current as Najla Nasr, Joey Lai, Rachel A. Botting, Sarah K. Mercier, of September 29, 2021. Andrew N. Harman, Min Kim, Stuart Turville, Rob J. Center, Teresa Domagala, Paul R. Gorry, Norman Olbourne and Anthony L. Cunningham J Immunol 2014; 193:2554-2564; Prepublished online 28 July 2014; Downloaded from doi: 10.4049/jimmunol.1400630 http://www.jimmunol.org/content/193/5/2554 Supplementary http://www.jimmunol.org/content/suppl/2014/07/26/jimmunol.140063 http://www.jimmunol.org/ Material 0.DCSupplemental References This article cites 60 articles, 30 of which you can access for free at: http://www.jimmunol.org/content/193/5/2554.full#ref-list-1 Why The JI? Submit online. by guest on September 29, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Primary Immunodeficiency Disorders
    ALLERGY AND IMMUNOLOGY 00954543 /98 $8.00 + .OO PRIMARY IMMUNODEFICIENCY DISORDERS Robert J. Mamlok, MD Immunodeficiency is a common thought among both patients and physicians when confronted with what is perceived as an excessive num- ber, duration, or severity of infections. Because of this, the starting point for evaluating patients for suspected immunodeficiency is based on what constitutes ”too many infections.” It generally is agreed that children with normal immune systems may have an average of 6 to 8 respiratory tract infections per year for the first decade of life. Even after a pattern of ab- normal infection is established, questions of secondary immunodeficiency should first be raised. The relatively uncommon primary immunodefi- ciency diseases are statistically dwarfed by secondary causes of recurrent infection, such as malnutrition, respiratory allergy, chronic cardiovascular, pulmonary, and renal disease, and environmental factors. On the other hand, a dizzying spiral of progress in our understanding of the genetics and immunology of primary immunodeficiency disease has resulted in improved diagnostic and therapeutic tools. Twenty-five newly recognized immunologic disease genes have been cloned in the last 5 ~ears.2~It has become arguably more important than ever for us to recognize the clinical and laboratory features of these relatively uncommon, but increasingly treatable, disorders. CLASSIFICATION The immune system has been classically divided into four separate arms: The B-cell system responsible for antibody formation, the T-cell sys- From the Division of Pediatric Allergy and Immunology, Texas Tech University Health Sci- ences Center, Lubbock, Texas PRIMARY CARE VOLUME 25 NUMBER 4 DECEMBER 1998 739 740 MAMLOK tem responsible for immune cellular regulation, the phagocytic (poly- morphonuclear and mononuclear) system and the complement (opsonic) system.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • Ic3b Catalog Number: A115 Sizes Available: 250 Μg/Vial Concentration
    Name: iC3b Catalog Number: A115 Sizes Available: 250 µg/vial Concentration: 1.0 mg/mL (see Certificate of Analysis for actual concentration) Form: Frozen liquid Purity: >90% by SDS-PAGE Buffer: 10 mM sodium phosphate, 145 mM NaCl, pH 7.2 Extinction Coeff. A280 nm = 1.03 at 1.0 mg/mL Molecular Weight: 176,000 Da (3 chains) Preservative: None, 0.22 µm filtered Storage: -70oC or below. Avoid freeze/thaw. Source: Normal human serum (shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II). Precautions: Use normal precautions for handling human blood products. Origin: Manufactured in the USA. General Description iC3b (inactivated C3b) is derived from C3b. Conversion of C3b to iC3b destroys almost all of the functional binding sites present on C3b. C3b itself is produced by all three pathways of complement (Law, S.K.A. and Reid, K.B.M. (1995)) when native C3 is cleaved releasing C3a. iC3b is prepared by cleavage of C3b by factor I in the presence of factor H. Cleavage by factors H and I occurs rapidly when the C3b is free in solution and is slower when it is attached to a surface. Other cofactors for factor I also permit cleavage if C3b to iC3b and these include the two membrane proteins CR1 (CD35) and MCP (CD46). Factor I can cleave C3b in two places in the alpha chain and if both sites are cleaved a small fragment (C3f, 2,000 Da) is released. If the C3b precursor was attached to a surface, the iC3b remains on that surface.
    [Show full text]